Skip to main content

ARKG Offers Exposure to Advancements in Synthetic Biology

New advances in synthetic biology uncovers lucrative investment opportunities for advisors. Sponsored by one of Novo Nordisk’s global research groups, a team of scientists recently installed one of the largest biosynthetic pathways––a series of biochemical reactions that occur inside an organism––into a strain of brewer’s yeast, Simon Barnett, ARK Invest’s director of research, life sciences, [...] The post ARKG Offers Exposure to Advancements in Synthetic Biology appeared first on ETF Trends .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.